| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.87B | +2.2% |
| Gross Profit | $2.33B | +3.8% |
| R&D Expense | $189.4M | +2.2% |
| SG&A Expense | $936.3M | +3.6% |
| Interest Expense | $74.6M | -3.5% |
| Pre-tax Income | $1.04B | +6.5% |
| Income Tax | $174.1M | -5.9% |
| Net Income | $863.1M | +9.4% |
| EPS (Basic) | $40.67 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $687.1M | +3.5% |
| Inventory | $342.3M | -11.3% |
| Current Assets | $1.19B | -3.0% |
| Total Assets | $3.24B | -3.4% |
| Current Liabilities | $1.17B | -1.1% |
| Long-term Debt | $1.83B | -3.0% |
| Total Liabilities | $3.37B | -4.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $968.3M | +0.3% |
| Capital Expenditures | $103.9M | -1.4% |
| Investing Cash Flow | -$119.5M | +9.3% |
| Financing Cash Flow | -$856.0M | +0.4% |
| Free Cash Flow | $864.4M | +0.5% |
| +12.7% |
| EPS (Diluted) | $40.48 | +12.8% |
| Stockholders' Equity |
| -$126.9M |
| +15.4% |